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Counselling to include tailored use of combined oral contraception (COC) in clinical practice 
– an evaluation. 
 
Introduction 
Combined oral contraception (COC, ‘the pill’) remains the most prescribed method of 
contraception in the UK.  Although a variety of regimens for taking monophasic COC are 
held to be clinically safe, women are not routinely counselled about these choices and there 
is a lack of evidence on how to provide this information to women. 
 
Aim 
To assess the usefulness and feasibility of including tailored use of monophasic COC within 




Using a structured format, health care professionals (HCPs) counselled new and established 
COC users attending an SRH service about standard and tailored ways of taking the pill.  
Questionnaires were used to survey both the HCPs and patients immediately after the initial 
consultation, and then the patients again eight weeks later. 
 
Results 
Nearly all patients (98%, n=95) felt it was helpful to be informed of the different ways of 
using monophasic COC by the HCP, without giving too much information at one time (96%, 
n=108).  The HCPs were confident of their COC counselling (99%, n=110) and did not think 
the consultations took significantly longer (88%, n=98).   
 
Conclusion 
This study demonstrates that information on different pill taking regimens is useful and 
acceptable to patients, and can improve contraceptive pill user choice.  It is also feasible for 
HCPs to perform COC counselling to include tailored pill use during routine consultations in 
a clinical setting. 
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Counselling to include tailored use of combined oral contraception (COC) in clinical practice – 
an evaluation 
Introduction  
Two million women are estimated to be using combined oral contraception (COC, ‘the pill’) 
in the Great Britain.1  England’s sexual and reproductive health (SRH) services provided COC 
to over 400,000 women in the last year, a figure that has remained fairly stable over the last 
decade.2,3  When the pill first became available in 1960 it was licensed for standard use 
which became the norm - taking the pill daily for 21 days, followed by seven pill-free days 
during which a ‘monthly’ withdrawal bleed occurs.  However alternative ways of taking the 
pill have slowly gained ground which have been grouped under tailored use.4 
Tailored pill use tends to be unlicensed by the pill manufacturer but is safe, and applies only 
to monophasic combined oral contraceptives.4,5  It includes:  
1. extended use with shortened pill free interval (PFI), where a woman takes a pill daily until 
bleeding for at least three consecutive days triggers a PFI of three or four consecutive days;   
2. tricycling, where one pill is taken every day for nine consecutive weeks followed by a pill 
free interval of seven days.   
We did a randomised controlled trial of tailored versus standard use to compare COC 
continuation rates at one year and user experience.6  In those women familiar with standard 
use of the COC at trial recruitment (83%, n=417), switching to tailored COC use or 
continuing with standard use were both associated with high COC continuation rates and 
high satisfaction with contraceptive regimen and bleeding pattern.  Tailored COC use was 
associated with significantly less bleeding, suited some women very well and can provide a 
suitable alternative to standard use. 
We also did a literature review on the evolution of extended COC use which concluded that 
women needed to be better informed about pill-taking regimens in line with scientific 
evidence. 7.     
Despite national guidance, supporting scientific evidence as well as health care 
professionals’ awareness, patients do not routinely receive counselling to include tailored 
pill use even in SRH services.8,9  There is a lack of evidence about how to provide such 
counselling effectively.   
We therefore wanted, as the next logical step, to assess the feasibility and usefulness of 
routinely providing information about different ways of taking the pill in a busy SRH service.  
 
Materials and Method 
A structured format and advice sheet for the study were developed and evaluated at the 
Margaret Pyke Centre, a London SRH service with an average of 18,000 attendances per 
year, of which about a fifth are for COC.  These tools that had been used for the tailored 
versus standard contraceptive pill use trial6 were combined, modified and validated to 
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produce a Script  for use by health care professionals (HCPs) and an Advice Sheet (see 
appendix 1) for patients to provide information on tailored COC use.  Questionnaires were 
also developed to obtain information from both the HCP and patient immediately after the 
initial consultation (HCP and patient baseline questionnaires), and again from the patient 
after eight weeks – either by telephone, email or in person at their follow up visit (follow up 
questionnaire). 
Recruitment to the study took place from 14 May 2015 until 14 March 2016, during which 
there were 3, 874 attendances for, or related to, COC.  Patients aged 18-45 wishing to start 
or currently taking COC, who were able to give written consent to participation including 
follow up by a short telephone interview, email questionnaire or during their next clinic visit 
eight weeks later, were invited to participate in the study.  These patients needed to be 
requesting COC as a contraceptive method for at least the next 3 months and should not 
have any recognised contraindications to COC use.4  All consultations took place with two 
experienced HCPs, trained to use the study’s Script to counsel patients on the different ways 
of taking COC as part of a routine COC consultation.  The COC counselling was done with the 
aid of the study’s Advice Sheet and the Family Planning Association leaflet ‘Your Guide to 
using the combined pill’10 as per usual clinic procedure. 
The sample size was obtained by estimating that the prevalence of patients agreeing it was 
helpful to be offered information on the different ways of COC use would be 80%, so that a 
sample of 100 of women would allow an estimate with good precision, with an expected 
95% confidence interval of 72% to 88%.  Allowing for 10% lost to follow up at 3 months we 
aimed to recruit 112 women.   
Descriptive statistics are presented in the tables for all patients who were eligible to 
participate and provided consent, and the HCPs that undertook consultations; and based on 
all available responses.  Formal statistical testing was carried out to compare ways of taking 
the pill chosen after the initial consultation and that at follow up, and to compare the ways of 
taking the pill chosen by patients after their initial consultation based on prior knowledge of 
more than one way of taking the pill (marginal homogeneity test and chi squared tests 
respectively).  All analyses were performed using StataSE 14.  A 5% significance level was 
used. 
 
Study procedure using the Script (see appendix 2) 
• Discussion of appropriate contraceptive methods after history taking. If patient 
chooses COC, further information was provided on this method (counselling) 
• During the consultation, the HCP discussed the different ways of using COC and 
provided information on tailored COC use in addition to that on standard COC use with the 
aid of the Script and Advice sheet respectively  
• Thereafter, the HCP informed the patient about the study and provided the 
Participant Information Sheet.  If the patient was willing to participate in the study, the HCP 
obtained the patient’s consent (written, using the Participant’s Consent Form).  After this, 
6 
 
the HCP gave the patient the baseline questionnaire for completion immediately after 
leaving the consultation room with her supplies of COC.  Should the patient require more 
time to decide on taking part, she could take the consent form and baseline questionnaire 
away with her and complete and return these to the service within one week of the visit (a 
stamped addressed envelope was provided in such circumstance) if she eventually decided 
to take part.   
• After the consultation, the HCP completed a questionnaire to give their opinion on 
how the counselling on the different ways of taking the pill went with the patient. 
• At eight weeks, the patient was followed up by their method of choice (phone, email 
or during their clinic visit) and the follow up questionnaire was completed. 
User involvement in the design and development of this study and study materials, including 
questionnaires and participant information, was from Involve@MPC - the Margaret Pyke 
Centre’s patients’ forum (a public engagement group) and experienced SRH clinicians. 
Ethical approval for this evaluation was granted following review by the Proportionate 
Review Sub-committee of the NRES Committee Yorkshire & The Humber – Leeds West, UK.  
Local NHS Research and Development approval was obtained from the North Central 
London Research Consortium.   
 
Results  
One hundred and twelve patients were recruited to the study.  Eighty-seven patients 
completed the follow up questionnaire at the end of the study.   Nearly all patients recruited 
(98%, n=110) were current or past pill users and two-thirds (68%, n=76) were already aware 
that there was more than one way of taking the pill.  Nearly all patients also responded that 
they understood the different ways of taking the COC that had been explained to them, they 
did not feel it was too much information at the time, and they found it helpful to have 
received all this information in one consultation. (Table 1) 
Straight after the initial consultation, tailored COC use (48%, n=53) was chosen by more 
patients than standard COC use (27%, n=30), with the tricycling way of taking the pill chosen by 
a third of patients (n=37).  Also, almost half (44%, n=16) of those patients who had stated that 
prior to their initial consultation they were only aware of standard COC use (n=36) chose the 
tailored way of taking the pill.  However there was no significant difference in the ways of taking 
the pill chosen by patients after their initial consultation based on prior knowledge of more 
than one way of taking the pill (p=0.374). 
At follow up 87 responses were received and most respondents (94%, n=82) were still using 
COC.  Majority (97%, n=84) also felt it was helpful to have been informed about the different 
ways of taking COC. (Table 2)  Twenty-one of the 82 patients still using COC at follow up  




Table 1: Patient baseline questionnaire responses (post initial consultation), N=112. 
Question Answer %, (n) 
1. I am clear about the three different ways 
the pill can be taken that has just been 
explained to me 
Strongly agree 25.5 (28) 
Agree 74.5 (82) 
Neither agree or disagree 0 
Disagree 0 
Strongly disagree 0 
2. I previously knew there was more than 
one way to take the pill 
No 32.1 (36) 
Yes 67.9 (76) 
3. I am already using or have used the pill 
in the past 
No 1.8 (2) 
Yes   98.2 (110) 
4. It was helpful to be told the three 
different ways to take the pill 
Strongly agree 71.1 (69) 
Agree 26.8 (26) 
Neither agree or disagree 2.1 (2) 
Disagree 0 
Strongly disagree 0 
5. It’s better to be told just one way of 
taking the pill 
Strongly agree 1.0 (1) 
Agree 2.1 (2) 
Neither agree or disagree 9.2 (9) 
Disagree 46.9 (46) 
Strongly disagree 40.8 (40) 
6. Hearing about more than one way of 
taking the pill was too much at one 
consultation 
Strongly agree 2.7 (3) 
Agree 0 
Neither agree or disagree 0.9 (1) 
Disagree 52.7 (59) 
Strongly disagree 43.7 (49) 
7. After receiving the information, my 
chosen way of taking the pill is: 
Standard 27.1 (30) 
Extended 14.4 (16) 
Tricycling 33.3 (37) 
Still undecided 25.2 (28) 
 
Table 2: Patient follow up questionnaire responses, N=87. 
Question Answer %, (n) 
1. I found it helpful to be given a choice of 
ways to take the combined pill 
Strongly agree 69 (60) 
Agree 27.6 (24) 
Neither agree or disagree 2.3 (2) 
Disagree 1.1 (1) 
Strongly disagree 0 
2. Being given the option of three ways of 
taking the pill has increased my chances 
of continuing with it 
 
Strongly agree 17.2 (15) 
Agree 26.4 (23) 
Neither agree or disagree 36.8 (32) 
Disagree 14.9 (13) 
Strongly disagree 4.7 (4) 
3. I have changed the way I decided to 
take the combined pill since the first 
questionnaire 
No 56.3 (49) 
Not sure 2.3 (2) 
Yes 41.4 (36) 
4. My current way of taking the combined 
pill is: 
  
*As reported by patients 
 
Standard 46.0 (40) 
Extended 18.4 (16) 
Tricycling 27.6 (24) 
No longer taken pills 5.7 (5) 
Bicycling*        2.3 (2) 
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There were therefore 61 responses available to compare the way of taking the pill chosen 
by patients after their initial consultation and then that at follow up.  Of these 61 patients, 
29% (n=17) had changed the way they took the COC since their initial consultation, a 
difference which was statistically significant (p=0.046).  One patient changed from standard 
to tailored (extended) COC use, 6 patients (extended n=1, tricycling n=5) changed from 
tailored to standard COC use, and 10 patients changed their way of tailored use – 2 changed 
from extended to tricycling, 1 patient from extended to bicycling, 6 patients from tricycling 
to extended and 1 patient from tricycling to bicycling. 
 
The HCPs were confident of their pill taking explanations (99%, n=110) and believed the 
patient to have understood and retained the information (98%, n=109) for almost every 
consultation.  Nearly half of the patients (48%, n=53) had demonstrated to the HCP some 
prior knowledge of the different ways of taking the pill.  No HCP reported that the 
consultation had taken significantly longer than it would have done if they had not followed 
Script. (Table 3) 
 
Table 3: HCP questionnaire responses (post initial consultation), N=111. 
Question Answer %, (n) 
1. I was able to clearly describe the three 
different ways the combined pill can be 
taken to the patient 
Strongly agree 69.4 (77) 
Agree 29.7 (33) 
Neither agree or disagree 0 
Disagree 0 
Strongly disagree 0.9 (1) 
2. The patient demonstrated previous 
knowledge of more than one way to take 
the combined pill 
No 52.3 (58) 
Yes 47.7 (53) 
3. Describing more than one way of taking 
the combined pill took too long for one 
consultation 
Strongly agree 0 
Agree 0 
Neither agree or disagree 11.7 (13) 
Disagree 73.0 (81) 
Strongly disagree 15.3 (17) 
4. It was helpful to be able to offer the 
patient three different ways of taking the 
combined pill 
Strongly agree 18.0 (20) 
Agree 65.8 (73) 
Neither agree or disagree 15.3 (17) 
Disagree 0.9 (1) 
Strongly disagree 0 
5. It is better to teach the patient just one 
way of taking the combined pill 
Strongly agree 0.9 (1) 
Agree 0 
Neither agree or disagree 4.5 (5) 
Disagree 83.8 (93) 
Strongly disagree 10.8 (12) 
6. The patient understood and retained the 
counselling information 
Strongly agree 32.4 (36) 
Agree 65.8 (73) 
Neither agree or disagree 1.8 (2) 
Disagree 0 




Discussion   
Our study findings show that counselling information including tailored COC use appeared 
to have been both conveyed by the HCPs and received by the patients very clearly.  This 
outcome was better than we had expected. Patients welcomed all the information and did 
not find it confusing, nor did the HCPs think it too time-consuming to discuss in one 
consultation.  COC counselling to include tailored use of the pill was determined feasible for 
HCPs as well as useful to patients with the aid of a Script and an Advice Sheet.   
We have tested a format of consultation that was experienced positively by both patients 
and HCPs; it gives patients additional useful information about the COC in a way that works 
within a busy SRH service.   As these findings are positive, there should be little difficulty in 
adopting this aspect of clinical practice within the service in conjunction with other 
members of the SRH team.   With the Script providing guidance to HCPs and the Advice 
Sheet an additional visual aid for patients during COC counselling, it seems that 
consultations take no longer than usual, perhaps because a structured format is followed.  
Patients will also receive improved contraceptive choice and advice and further, can make 
their own decision on which way to take their pill. 
Only two-thirds (n=53) of those patients who stated on their questionnaire they were 
previously aware of more than one way of taking the pill (n=76), appeared to have shared 
this information with their HCP.   This finding may not be surprising.  For many years, some 
established COC users have skipped their pill free intervals to avoid withdrawal bleeds with 
or without discussion with a HCP.   A picture has emerged from research and clinical 
experience that some patients may feel they are doing something reprehensible by straying 
from the standard way of taking the pill, even though an alternative regimen may suit them 
better.   Some patients may consider it unwise to skip a PFI since it is unlicensed or having 
not been advised by a HCP to do so.  Or they may deem it unhealthy not to have a ‘period’ 
monthly. 11,12  Such patients may not confess to tailored pill use.    
Our study findings may be considered contrary to those of a randomised trial 13 that used a 
version of a WHO decision-making tool for structured contraceptive counselling as an 
intervention in comparison to their usual physician individualised counselling on effective 
contraceptive options.  Recipients of structured contraceptive counselling were not more 
likely to choose a very effective contraceptive method or initiate their method compared to 
recipients of usual care.   However this study was in a different clinical setting and following 
termination of pregnancy.  Also, their outcomes were choice and initiation of methods of 
contraception and not the feasibility or usefulness of informing patients of different ways of 
using their chosen contraceptive method.  
A possible limitation of our study is the fact that only two participants were new COC users. 
It would be useful to gain information from more women starting the COC for the first time.   
A second limitation could be that we did not ask current COC users which way they were 
taking the pill at their initial visit.  Also, the number of patients who had changed the way 
they were taking their COC some weeks later at follow up may be reflective of the HCPs not 
warning patients they may need more time to adjust to tailored COC use if they chose this 
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way of pill taking.14  We did not to collect demographic information, such as age, parity or 
educational attainment.  This was in line with recommendations of our public engagement 
group and the need for the questionnaire to be as short and anonymous as possible.    
We used a structured format for COC counselling with specialists in SRH, hence some of our 
study outcomes, for example similar duration of consultation, may not be generalisable to 
other clinical settings like general practice or pharmacy.  HCPs in the study had not been 
asked to time the consultations.  So their responses on whether the consultation took too 
long as a result of discussing different ways of taking the pill was opinion based.  However 
both Script and Advice Sheet were brief, had been developed in conjunction with HCPs and 
been validated for use in patient consultations.  There is also evidence that structured 
contraceptive counselling can be provided effectively by non-SRH specialists in a clinical 
research setting 15 so it is likely that this intervention can be successfully used by non-SRH 
specialists and in other clinical settings.   
The option of tailored COC use is believed to be one of the most important changes since 
the pill became available over five decades ago.16  Tailored pill use does not reduce COC 
efficacy nor cause significantly more side effects than standard pill use.  In fact, studies have 
reported similar safety, increased efficacy, the alleviation of menstrual symptoms and 
acceptable bleeding patterns with tailored COC use.5,6,17-22  We therefore recommend that 
HCPs consider routinely including information about tailored COC use for patients in 
different clinical settings.  Further research could explore the benefits and disadvantages 
with new COC users and explore demographic or contextual factors that might affect 
information on tailored COC use being given by HCPs or understood or accepted by patients. 
COC is a user dependent contraceptive method.  Hence correct use and user satisfaction will 
affect the efficacy and continuation of the method respectively.   There appears to be no 
evidence that counselling in a clinical setting reduces unintended pregnancy rates.23  
Nevertheless, for a contraceptive method that is widely used the potential to better 
efficacy, improve choice and COC users finding the information useful, this structured 
counselling is unlikely to be harmful.  Structured counselling is also patient-centred, 
standardised, and uses visual aids to provide adequate information during the consultation, 
which is efficient for both HCPs and patients.24 
 
Conclusion  
A structured format by which patients are informed by their HCP about the different ways of 
COC use during routine consultations has not been reported in the literature as far as we are 
aware.  Our study does not provide a quality of evidence comparable to that of a 
randomised trial but its findings are interesting and potentially useful for consultations 
regarding COC.  Patients value information on tailored COC use in addition to standard use 
of COC.  This information can be provided in a structured manner and using aids - a Script 
for the HCP and an Advice Sheet for the patient - during routine counselling prior to 
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Evidence for tailored use 
FRSH has issued guidance 
supporting taking the combined 
oral contraceptive pill in the 
tricycling manner.  It is noted, 
however, that this is ‘off licence’ 
use.   
Tricycling use of the combined 
oral contraceptive pill 
Patient Instructions 
What is tricycling pill taking?  
Taking the pill continuously without 
any breaks between strips for three 
strips (9weeks).  You then take a 
break for 7 consecutive days during 
which time a bleed will occur.  
Continue in this way and keep a 
record of bleeding. 
 
When to start 
Start the pill on day 1-5 of your cycle. The 
pill can be started on any other day in the 
cycle if there is no risk of pregnancy, 
however in this circumstance you need to 
use another form of protection for the first 
7 days. If you are already on a COC, 
patch, or vaginal ring method,  implant, 
injection or desogestrel-only POP, and 
transferring directly over to the extended 
pill use, you do not need added 
precautions. If you are switching from 
IUD/S or any other POP you need to use 
added precautions for 7 days.  
How to do tricycling pill taking 
You need to take the pill each day without any breaks for at least the first 21 
days.  Keep on taking the pill until you have taken three strips continuously (9 
weeks)  Then stop for 7 days.  Continue taking the pill in this manner (3 strips 
continuously followed by 7 days off). 
Evidence for extended use 
FRSH has issued guidance for 
the combined oral 
contraceptive pill that 
extended use is a reasonable 
approach to taking the 
combined oral contraception.  
It is noted, however, that this is 
‘off licence’ use.   
Extended use of the combined 
oral contraceptive pill 
Patient Instructions 
What is extended pill taking?  
Taking the pill continuously without 
any breaks between strips.  If 
bleeding occurs at any point for 3 
continuous days (bleeding requiring 
use of a pad or tampon), then stop 
the pill for 3-4 consecutive days, And 
Then re-start irrespective of whether 
the bleeding has stopped.  This 
discourages further irregular 
bleeding.  Continue in this way and 
keep a record of any bleeding. 
When to start 
Start the pill on day 1-5 of your cycle. The 
pill can be started on any other day in 
the cycle if there is no risk of pregnancy, 
however in this circumstance you need 
to use another form of protection for the 
first 7 days. If you are already on a COC, 
patch, or vaginal ring method,  implant, 
injection or desogestrel-only POP, and 
transferring directly over to the extended 
pill use, you do not need added 
precautions. If you are switching from  
IUD/S or any other POP you need to use 
added precautions for 7 days.  
 
How to do extended pill taking 
You need to take the pill each day for at least the first 21 days without any 
breaks until bleeding occurs for 3-4 continuous days (don’t worry if this 
doesn’t happen to you, it doesn’t occur with everyone). Stop taking the pill 
for 3-4 days, even if the bleeding stops. Then resume taking the pill every day, 
and when the pack is finished go straight on to the next pack. 
14 
 














1. Discuss all contraception types: LARC, 
oral and other (e.g. barriers) 
2. Patient selects contraception type
3. If combined pill is selected method, 
counsel patient using Advice Sheet and 
following Script.
4. Inform about study, obtain consent, 
provide initial questionnaire and arrange 
follow up questionnaire completion -
phone call, email or visit
